RECENT NEWS

Haier Biomedical – a brand synonymous with cold chain storage – has launched a comprehensive range of benchtop centrifuges. Using its extensive knowledge of temperature controlled sample handling and innovative approach to product design, the company has created three benchtop, high-speed refrigerated centrifuges offering industry-leading features.

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced it is taking forward its new ‘regulatory sandbox’, the AI-Airlock, that will provide a regulator-monitored virtual area for developers to generate robust evidence for their advanced technologies.

Four trusts in the Greater Manchester Pathology Network are working to deploy a Clinisys laboratory information management system (LIMS) in a way that will enable them to work more collaboratively and improve services for clinicians and patients. The four trusts will deploy a standardised, interfaced version of WinPath Enterprise to support collaboration and lay the foundation for further innovation.

Diagnostics firm LumiraDx has unveiled a new strategic collaboration with Everton in the Community - the official charity of Everton FC - to set up England’s first community-based heart and lung screening hub, set to go live this month.

Guy Orchard tells us about his presentation at IBMS Congress: ‘Complex and unusual case studies in Mohs’ as well as on his long association with the event and forthcoming changes at Synnovis.

Digital pathology and clinical AI firm Paige has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation for Paige Lymph Node, an AI application used to detect breast cancer metastases in lymph node tissue. Paige Lymph Node is the first AI application of its kind to receive such designation from the FDA.

The World Health Organization (WHO) has released its 2023 Essential Diagnostics List (EDL), which is an evidence-based register of in vitro diagnostics (IVD) which supports countries to make national diagnostic choices.

Beckman Coulter Life Sciences and single cell and spatial biology firm 10x Genomics, have announced a new partnership to expand automation solutions for single-cell assay workflows.

Thermo Fisher Scientific has reached an agreement with the board of directors of Olink, a next-generation proteomics solutions provider based in Sweden, to acquire the firm for $26 per share, valuing it at approximately $3.1 billion.

Clinisys Chief Marketing Officer Paul Jackson reveals the conversations Clinisys is having with new and potential customers at IBMS Congress, as well as looking ahead to the next 12 months for his company.

Next-generation sequencing (NGS) has revolutionized the field of genomics. However, sample and library preparation for NGS workflows are notoriously complex, time consuming and error prone when performed manually. Now, a new solution is at hand with the introduction of MIRO CANVAS.

Two new reports from the Centre for Process Innovation (CPI) reveal the UK urgently needs to deliver a medical technology industrial strategy to avoid falling behind in the rapidly growing health technology sector in the UK.

Roche has announced the US launch of the cobas connection modules (CCM) Vertical, the elevator and overhead components of its fully automated and modular CCM system to help low-, mid- and high-volume laboratories optimise space, productivity and patient care.

A new report by the BioIndustry Association (BIA) highlights the UK TechBio sector as thriving, with a growing number of companies pioneering groundbreaking products and services, seamlessly integrating biotechnology and technology.

Funding totalling £10 million is available to bodies working on tackling antimicrobial resistance (AMR) as part of UK Research and Innovation (UKRI) tackling infections strategic theme.

Paul Ladestein, Director, Commercial Operations Northern Europe at Beckman Coulter, tells PiP about his company’s new Dxl 9000 Analyser, on show for the first time in the UK at IBMS Congress, as well as explaining how Beckman Coulter is bringing innovation into its customers’ laboratories.

Mayo Clinic and Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, have unveiled a multi-year joint development collaboration to develop new clinical tests for diseases and improve patient care.

The World Health Organization (WHO) has released a new publication listing key regulatory considerations on artificial intelligence (AI) for health. The publication emphasises the importance of establishing AI system safety and effectiveness, rapidly making appropriate systems available, and fostering dialogue among stakeholders.

Roche has announced that its Elecsys IL-6 immunoassay has become the first interleukin-6 (IL-6) test to have a certified claim for use in diagnosis of neonatal sepsis, in countries accepting the CE Mark.

Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways to Antimicrobial Clinical Efficacy), a £30 million initiative supporting early-stage innovation against antimicrobial resistance (AMR) to save lives.